Status:
COMPLETED
Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare two strategies of catheter-based treatment of paroxysmal atrial fibrillation: Pulmonary vein isolation either alone or combined with electrogram-guided substrat...
Detailed Description
Catheter ablation has evolved an accepted alternative in the curative treatment of atrial fibrillation (AF). However, discussion about the best ablation strategy is still ongoing. In patients with pa...
Eligibility Criteria
Inclusion
- Age \> 18 and \<80 years
- Symptomatic paroxysmal atrial fibrillation
- Drug-refractory
- Anticoagulation
Exclusion
- Hyperthyreosis
- Moderate-to-severe mitral valve valvulopathy
- LV-ejection fraction \<35%
- Prior ablation, PCI or heart surgery \<3 months
- Left atrial thrombus
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00196183
Start Date
August 1 2004
End Date
June 1 2006
Last Update
March 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636